Fanconi Anemia Research To Be Accelerated

Links shared publicly online about this topic.

  • 1,133
    total visits

Fanconi Anemia Research To Be Accelerated

medicalnewstoday.com

National Institute of Health grant expands OHSU's 15-year research effort into the cause, prevention, treatment of the diseaseOregon Health & Science University is partnering with the Un

View full resource at medicalnewstoday.com

Tags: Anemia, Genetic

  • Share

Most Recently Shared on May 29, 2010 at 2:05 pm By:

Also Shared By:

MNT Leukemia MNT Leukemia

MNT Blood MNT Blood

Experimental Drug Could Protect Some Cancer Patients from Radiation Side Effects, UPCI Researchers Find – UPMC, Pittsburgh, PA, USA

upmc.com — “A drug under development at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine could protect the cells of Fanconi anemia patients from damage caused by radiation treatment for head and neck cancers.View full resource at upmc.com

  • View Related
  • Share

Most Recently Shared on October 8, 2011 at 10:56 am By:

oncopharm Ruth Stephen Health Advocate

A drug can protect patients against damage caused by radiation treatment http://t.co/FvhdqqNq

6 months ago...

Experimental drug could protect from radiatition side effects - National Cancer Institute

cancer.gov — “A drug under development at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine could protect the cells of Fanconi anemia patients from damage caused by radiation treatment for head and neck cancers, aView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 5:34 pm By:

NCIMedia NCI Media Relations

In @UPMCnews: researchers find experimental drug could offer patients protection from radiation-induced esophagitis http://j.mp/n3xSZs

6 months ago...

NIH awards $3.9M for Fanconi anemia research

news-medical.net — “The National Institutes of Health has awarded a three-year, $3.9 million grant to Children's Hospital Boston researchers and their colleagues to develop a therapy to treat Fanconi anemia, a fatal genetic blood disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 25, 2010 at 11:25 am By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: NIH awards $3.9M for Fanconi anemia research: The National Institutes of Health has awarded a three... http://bit.ly/aNH7RD

1 year ago...

Replication at DNA Damage Sites Highlights Fanconi Anemia and Breast Cancer Proteins - MD Anderson Cancer Center

mdanderson.org — “While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.View full resource at mdanderson.org

  • View Related
  • Share

Most Recently Shared on September 14, 2009 at 11:41 am By:

Rndubois Raymond DuBois Health Executive, Physician, Doctor, Internist, and Gastroenterologist

MD Anderson scientists report (in Mol. Cell) that DNA damage sites recruit both FA and BRCA cancer proteins: http://tinyurl.com/rblyl6

3 years ago...

eChIP genetic technique developed to examine FA proteins with DNA crosslinks

news-medical.net — “While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 11, 2009 at 7:12 am By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: eChIP genetic technique developed to examine FA proteins with DNA crosslinks: While.. http://bit.ly/712bt

3 years ago...

Replication at DNA Damage Sites Highlights Fanconi Anemia and Breast Cancer Proteins

newswise.com — “While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 6:29 pm By:

mednewswise Thom Canalichio Health News

Replication at DNA Damage Sites Highlights Fanconi Anemia and Breast Cancer Proteins http://bit.ly/daUsX

3 years ago...

Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins

physorg.com — “While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly hereditary types of breast cancer.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 5:50 pm By:

FightCancer FightCancer Health News

Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins http://bit.ly/x0WfZ

3 years ago...

Advertisement